Sygnature Discovery
http://www.sygnaturediscovery.com
Sygnature Discovery is a leading United Kingdom-based provider of integrated drug discovery services to the global pharmaceutical industry. Key areas of expertise include medicinal and synthetic chemistry, computational chemistry and bioscience (in vitro biology and screening). The company was founded in 2004 in BioCity Nottingham.
Sygnature’s team of over 50 industry-experienced chemists and biologists add considerable value to its clients’ drug discovery activities by undertaking complete drug discovery programmes and key elements of the drug discovery process, such as hit finding, hit-to-lead and lead optimisation. Sygnature’s scientists also provide considerable intellectual input into clients’ projects; thereby generating novel intellectual property. The integrated drug discovery services on offer at Sygnature include:
- Medicinal chemistry
- Synthetic chemistry
- Computational chemistry
- Bioscience (in vitro biology and screening)
- Arrays and libraries
- Process and scale-up Chemistry
- ADME/toxicology (via a strategic alliance with Cyprotex Discovery)